Law360 (subscription) ... partial dismissal in which Takeda agreed to drop its claims that Lupin infringed on three of Takeda's four patents for Prevacid when it sought federal approval to launch a generic version of lansoprazole , the active ingredient in delayed-release ... and more »
Law360 (subscription) ... partial dismissal in which Takeda agreed to drop its claims that Lupin infringed on three of Takeda's four patents for Prevacid when it sought federal approval to launch a generic version of lansoprazole , the active ingredient in delayed-release ...
Financial Post The Minister of Health refused to grant data protection to Takeda on the basis that Dexilant was a variation of a previously approved drug because it was an enantiomer (a non-identical mirror image) of a previously approved drug, lansoprazole . “The FCA ...
